Your browser doesn't support javascript.
Digital PCR can augment the interpretation of RT-qPCR Cq values for SARS-CoV-2 diagnostics.
Whale, Alexandra S; von der Heide, Eva K; Kohlenberg, Max; Brinckmann, Anja; Baedker, Silke; Karalay, Oezlem; Fernandez-Gonzalez, Ana; Busby, Eloise J; Bustin, Stephen A; Hauser, Heiko; Missel, Andreas; O'Sullivan, Denise M; Huggett, Jim F; Pfaffl, Michael W; Nolan, Tania.
  • Whale AS; National Measurement Laboratory, LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK. Electronic address: Alexandra.Whale@lgcgroup.com.
  • von der Heide EK; LGC Genomics GmbH, Research and Development, TGS Haus 8, Ostendstraße 25, 12459 Berlin, Germany. Electronic address: Eva.vonderHeide@LGCGroup.com.
  • Kohlenberg M; LGC Genomics GmbH, Research and Development, TGS Haus 8, Ostendstraße 25, 12459 Berlin, Germany. Electronic address: Max.Kohlenberg@LGCGroup.com.
  • Brinckmann A; LGC Genomics GmbH, Research and Development, TGS Haus 8, Ostendstraße 25, 12459 Berlin, Germany. Electronic address: Anja.Brinckmann@LGCGroup.com.
  • Baedker S; QIAGEN GmbH, Research and Development, QIAGEN Strasse 1, 40724 Hilden, Germany. Electronic address: Silke.Baedker@qiagen.com.
  • Karalay O; QIAGEN GmbH, Research and Development, QIAGEN Strasse 1, 40724 Hilden, Germany. Electronic address: Oezlem.Karalay@qiagen.com.
  • Fernandez-Gonzalez A; National Measurement Laboratory, LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK. Electronic address: Ana.Fernandez-Gonzalez@LGCGroup.com.
  • Busby EJ; National Measurement Laboratory, LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK. Electronic address: Eloise.Busby@lgcgroup.com.
  • Bustin SA; Molecular Diagnostics Unit, Medical Technology Research Centre, Anglia Ruskin University, UK. Electronic address: stephen.bustin@aru.ac.uk.
  • Hauser H; LGC Genomics GmbH, Research and Development, TGS Haus 8, Ostendstraße 25, 12459 Berlin, Germany. Electronic address: Heiko.Hauser@LGCGroup.com.
  • Missel A; QIAGEN GmbH, Research and Development, QIAGEN Strasse 1, 40724 Hilden, Germany. Electronic address: Andreas.Missel@qiagen.com.
  • O'Sullivan DM; National Measurement Laboratory, LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK. Electronic address: denise.osullivan@lgcgroup.com.
  • Huggett JF; National Measurement Laboratory, LGC, Queens Road, Teddington, Middlesex TW11 0LY, UK; School of Biosciences & Medicine, Faculty of Health & Medical Sciences, University of Surrey, Guildford, Surrey GU2 7XH, UK. Electronic address: Jim.Huggett@lgcgroup.com.
  • Pfaffl MW; Division of Animal Physiology and Immunology, School of Life Sciences Weihenstephan, Technical University of Munich, Munich, Germany. Electronic address: michael.pfaffl@wzw.tum.de.
  • Nolan T; LGC Genomics GmbH, Research and Development, TGS Haus 8, Ostendstraße 25, 12459 Berlin, Germany; Molecular Diagnostics Unit, Medical Technology Research Centre, Anglia Ruskin University, UK. Electronic address: Tania.Nolan@lgcgroup.com.
Methods ; 201: 5-14, 2022 05.
Article in English | MEDLINE | ID: covidwho-1373305
ABSTRACT
Coronavirus disease 2019 (COVID-19) is an infectious, acute respiratory disease caused mainly by person-to-person transmission of the coronavirus SARS-CoV-2. Its emergence has caused a world-wide acute health crisis, intensified by the challenge of reliably identifying individuals likely to transmit the disease. Diagnosis is hampered by the many unknowns surrounding this disease, including those relating to infectious viral burden. This uncertainty is exacerbated by disagreement surrounding the clinical relevance of molecular testing using reverse transcription quantitative PCR (RT-qPCR) for the presence of viral RNA, most often based on the reporting of quantification cycles (Cq), which is also termed the cycle threshold (Ct) or crossing point (Cp). Despite it being common knowledge that Cqs are relative values varying according to a wide range of different parameters, there have been efforts to use them as though they were absolute units, with Cqs below an arbitrarily determined value, deemed to signify a positive result and those above, a negative one. Our results investigated the effects of a range of common variables on Cq values. These data include a detailed analysis of the effect of different carrier molecules on RNA extraction. The impact of sample matrix of buccal swabs and saliva on RNA extraction efficiency was demonstrated in RT-qPCR and the impact of potentially inhibiting compounds in urine along with bile salts were investigated in RT-digital PCR (RT-dPCR). The latter studies were performed such that the impact on the RT step could be separated from the PCR step. In this way, the RT was shown to be more susceptible to inhibitors than the PCR. Together, these studies demonstrate that the consequent variability of test results makes subjective Cq cut-off values unsuitable for the identification of infectious individuals. We also discuss the importance of using reliable control materials for accurate quantification and highlight the substantial role played by dPCR as a method for their development.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Methods Journal subject: Biochemistry Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Methods Journal subject: Biochemistry Year: 2022 Document Type: Article